卫光生物公布三季报 前三季净利减少13.6%

Core Viewpoint - Weigao Bio released its third-quarter report, indicating a decline in both revenue and net profit compared to the previous year [1]. Financial Performance - The company's revenue for the first three quarters amounted to 790,899,107.60 yuan, representing a year-on-year decrease of 7.4% [1]. - The net profit attributable to shareholders of the listed company was 157,860,537.25 yuan, which is a year-on-year decrease of 13.6% [1]. Shareholder Changes - Among the top ten circulating shareholders, new entrants include Shenzhen Weigao Biological Products Co., Ltd. - Phase III Employee Stock Ownership Plan, Hong Kong Central Clearing Limited, and Nie Haiyan [1].